← Eichor
Condition: Brain Glioma Synced from ClinicalTrials.gov · July 30, 2026

Recruiting studies: Brain Glioma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Focused Ultrasound Blood-Brain Barrier Disruption for the Treatment of High-Grade Glioma in Patients Undergoing Standard
Phase 1 · 1 location(s) · Sunnybrook Health Sciences Centre · NCT07179328Surgical Tissue Flap to Bypass the Blood Brain Barrier in Glioblastoma
NA · 1 location(s) · Northwell Health · NCT05954858Tessa Jowell BRAIN MATRIX - Platform Study
Phase N/A · 14 location(s) · University of Birmingham · NCT04274283Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Phase 1 · 1 location(s) · Florida International University · NCT05857969A Study Utilizing Escitalopram in Glioma Patients
Phase 2 · 1 location(s) · University of Nebraska · NCT03728673Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma
Phase 2 · 1 location(s) · Northwestern University · NCT05864534ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids
Phase 2 · 22 location(s) · University of Birmingham · NCT05629702Autologous CAR-T Cells Targeting B7-H3 in Recurrent or Refractory GBM CAR.B7-H3Tc
Phase 1 · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT05366179GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
Phase 1 · 1 location(s) · Baylor College of Medicine · NCT06815432Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age
Phase 1/Phase 2 · 1 location(s) · University of Miami · NCT05956821Chronic CED of TPT for Recurrent Malignant Glioma
Phase 1 · 1 location(s) · Jeffrey N. Bruce · NCT06666712Low-grade Gliomas in Argentina: Incidence, Survival, and Therapeutic Strategies
Phase N/A · 6 location(s) · Hospital Italiano de Buenos Aires · NCT07631338A Phase 0/1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refra
EARLY_Phase 1 · 1 location(s) · Children's National Research Institute · NCT07017816A Phase 0/1 Clinical Trial With an Expansion Phase of GSK5764227, a B7-H3-Targeted Antibody-Drug Conjugate (ADC), in Pat
EARLY_Phase 1 · 1 location(s) · Nader Sanai · NCT07268053Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
Phase 1/Phase 2 · 1 location(s) · Northwell Health · NCT01269853The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
Phase N/A · 8 location(s) · Jasper Gerritsen · NCT06146725Magnetic Resonance Elastography in Glioma: Exploring Tumor Stiffness and Adhesion
NA · 1 location(s) · Shengjing Hospital · NCT05990244Measure of the Potential Evoked by Electric Stimulation
NA · 1 location(s) · University Hospital, Montpellier · NCT02509442International HIT-MED Registry (I-HIT-MED)
Phase N/A · 57 location(s) · Universitätsklinikum Hamburg-Eppendorf · NCT0241732468-Ga DOTATATE PET/MRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.
Phase 4 · 1 location(s) · Weill Medical College of Cornell University · NCT04081701Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Phase 1/Phase 2 · 15 location(s) · Tango Therapeutics, Inc. · NCT06810544Non-invasive Glioma Characterization Through Molecular Imaging
NA · 1 location(s) · University of Miami · NCT03684109ViCToRy: Vorasidenib in Combination With Tumor Specific Peptide Vaccine for Recurrent IDH1 Mutant Lower Grade Gliomas
Phase 1 · 1 location(s) · Katy Peters, MD, PhD · NCT05609994A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced So
Phase 1 · 83 location(s) · Pfizer · NCT05538130Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1
Phase 2 · 1 location(s) · Washington University School of Medicine · NCT07462507DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusio
Phase 2/Phase 3 · 27 location(s) · Cancer Research UK · NCT05770544IL-8 Receptor-modified CD70 CAR T Cell Therapy in CD70+ Adult Glioblastoma
Phase 1 · 1 location(s) · University of Florida · NCT05353530Glutamate Inhibitors in Glioblastoma
Phase 1/Phase 2 · 1 location(s) · University of Zurich · NCT05664464Phase 1 Study of Locoregional Injections of Ex Vivo Expanded Natural Killer Cells
Phase 1 · 1 location(s) · Nationwide Children's Hospital · NCT04254419Effect of Metformin on Behaviour and the Brain in Children Treated for a Brain Tumour
Phase 3 · 20 location(s) · Donald Mabbott · NCT05230758
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.